Cannabinoid Control of Fear Extinction Neural Circuits in Humans

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy Participants
Interventions
DRUG

Dronabinol

Dronabinol (7.5mg) is administered only once by the oral route and is placed in opaque capsules with dextrose filler. Half of the participants will receive dronabinol.

DRUG

Placebo

Placebo is administered only once by the oral route and contains only dextrose in opaque capsules. Half of the participants will receive placebo.

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Illinois at Chicago

OTHER

NCT02472847 - Cannabinoid Control of Fear Extinction Neural Circuits in Humans | Biotech Hunter | Biotech Hunter